Intellectus Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.29M Sell
10,089
-200
-2% -$25K 0.26% 100
2025
Q4
$1.25M Sell
10,289
-25
-0.2% -$2.87K 0.24% 109
2025
Q3
$1.03M Sell
10,314
-1,800
-15% -$162K 0.2% 128
2025
Q2
$1M Buy
12,114
+1,175
+11% +$93.7K 0.22% 127
2025
Q1
$887K Sell
10,939
-225
-2% -$20.1K 0.22% 135
2024
Q4
$1.01M Buy
11,164
+425
+4% +$41.2K 0.22% 119
2024
Q3
$1.06M Sell
10,739
-595
-5% -$58.5K 0.27% 109
2024
Q2
$1.05M Buy
11,334
+113
+1% +$10.1K 0.29% 99
2024
Q1
$1.06M Sell
11,221
-1,050
-9% -$97.4K 0.28% 103
2023
Q4
$1.1M Sell
12,271
-110
-0.9% -$8.17K 0.32% 89
2023
Q3
$904K Sell
12,381
-355
-3% -$28.4K 0.29% 100
2023
Q2
$1.06M Buy
12,736
+708
+6% +$59.2K 0.32% 88
2023
Q1
$917K Buy
12,028
+100
+0.8% +$8.3K 0.29% 102
2022
Q4
$990K Sell
11,928
-350
-3% -$28.3K 0.34% 85
2022
Q3
$974K Buy
12,278
+165
+1% +$13.9K 0.35% 80
2022
Q2
$900K Buy
12,113
+2,917
+32% +$219K 0.31% 87
2022
Q1
$827K Sell
9,196
-1,970
-18% -$182K 0.25% 106
2021
Q4
$1.25M Buy
11,166
+200
+2% +$24.1K 0.32% 83
2021
Q3
$1.38M Buy
10,966
+350
+3% +$45.1K 0.33% 80
2021
Q2
$1.44M Buy
10,616
+1,650
+18% +$217K 0.32% 79
2021
Q1
$1.22M Buy
8,966
+2,730
+44% +$409K 0.33% 81
2020
Q4
$878K Buy
6,236
+1,300
+26% +$167K 0.26% 118
2020
Q3
$550K Sell
4,936
-9,117
-65% -$1.02M 0.21% 130
2020
Q2
$1.57M Buy
14,053
+90
+0.6% +$8.86K 0.61% 41
2020
Q1
$1.08M Buy
13,963
+1,025
+8% +$90.8K 0.52% 46
2019
Q4
$1.23M Buy
12,938
+559
+5% +$48.4K 0.5% 53
2019
Q3
$944K Sell
12,379
-400
-3% -$33.2K 0.41% 67
2019
Q2
$1.12M Buy
12,779
+142
+1% +$12.1K 0.49% 59
2019
Q1
$1.14M Buy
+12,637
New +$1.08M 0.49% 51
2018
Q4
Sell
-10,719
Closed -$1.03M 544
2018
Q3
$1.03M Buy
10,719
+462
+5% +$44.8K 0.36% 77
2018
Q2
$976K Buy
10,257
+1,285
+14% +$118K 0.36% 74
2018
Q1
$787K Sell
8,972
-293
-3% -$26.7K 0.27% 97
2017
Q4
$786K Buy
9,265
+5,397
+140% +$452K 0.29% 96
2017
Q3
$335K Buy
+3,868
New +$310K 0.14% 165

Other funds holding XBI